NAUREX

Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs), which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.

#SimilarOrganizations #People #Financial #Website #More

NAUREX

Social Links:

Linkedin

Industry:

Biopharma Biotechnology Therapeutics

Founded:

2008-01-01

Address:

Evanston, Illinois, United States

Country:

United States

Website Url:

http://www.naurex.com

Total Employee:

11+

Status:

Active

Contact:

(847) 871-0377

Email Addresses:

[email protected]

Total Funding:

200.11 M USD

Technology used in webpage:

McAfee SaaS Email

Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

george-miljanich_image

George Miljanich Member of the Board of Advisor @ Naurex
Advisor

robert-j-hombach_image

Robert J. Hombach Board of Director @ Naurex
Board_member

not_available_image

Ian Ferrie Board of Director @ Naurex
Board_member

not_available_image

Derek Small Board of Director @ Naurex
Board_member

ken-widder_image

Ken Widder Board of Director @ Naurex
Board_member

terry-gould_image

Terry Gould Board of Director @ Naurex
Board_member

Current Employees Featured

joseph-moskal_image

Joseph Moskal
Joseph Moskal Founder & Chief Scientific Officer @ Naurex
Founder & Chief Scientific Officer

norbert-riedel_image

Norbert Riedel
Norbert Riedel CEO and Board of Director @ Naurex
CEO and Board of Director
2014-01-01

j-david-leander_image

J. David Leander
J. David Leander Chief Scientific Advisor @ Naurex
Chief Scientific Advisor

not_available_image

M. Amin Khan
M. Amin Khan Head of Chemistry @ Naurex
Head of Chemistry

wilbur-gantz_image

Wilbur Gantz
Wilbur Gantz Executive Chairman and Board of Director @ Naurex
Executive Chairman and Board of Director

Founder

joseph-moskal_image

Joseph Moskal

Investors List

goudy-park-capital_image

Goudy Park Capital

Goudy Park Capital investment in Series C - Naurex

sabby-capital_image

Sabby Capital

Sabby Capital investment in Series C - Naurex

adams-street-partners_image

Adams Street Partners

Adams Street Partners investment in Series C - Naurex

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series C - Naurex

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series C - Naurex

cowen-group_image

Cowen Group

Cowen Group investment in Series C - Naurex

baxter-ventures_image

Baxter Ventures

Baxter Ventures investment in Series C - Naurex

pathocapital_image

PathoCapital

PathoCapital investment in Series C - Naurex

portal-capital_image

Portal Capital

Portal Capital investment in Series C - Naurex

savitr-capital_image

Savitr Capital

Savitr Capital investment in Series C - Naurex

Official Site Inspections

http://www.naurex.com

Host Informations
Whois Informations

Loading ...

More informations about "Naurex" on Search Engine